According to reports reaching oyogist.com, the Government of Peru has ordered that all clinical trials for the Covid-19 vaccine, developed by Chinese drug giant Sinopharm, should be suspended.
Peru’s National Health institute further confirmed that it would halt the trail, after a volunteer had difficulty moving their arms, according to local media.
“Several days ago we signaled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome,” said chief researcher German Malaga in comments to the press.Peru’s clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
